MeiraGTx
MGTX
A$12.61
Share price
-1.67%
Change (1 day)
67.97%
Change (1 year)
P/S ratio for MeiraGTx (MGTX)
P/S ratio as of July 2025 (TTM): 19.2
According to MeiraGTx's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 20.0. At the end of 2025 the company had a P/S ratio of 16.7.
P/S ratio history for MeiraGTx from 2018 to 2025
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2025 | 16.7 | 14.85% |
| 2024 | 14.6 | -54.21% |
| 2023 | 31.9 | 60.43% |
| 2022 | 19.9 | -29.06% |
| 2021 | 28.0 | -34.89% |
| 2020 | 43.0 | -22.43% |
| 2019 | 55.4 | |
| 2018 | N/A |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 Novocure
NVCR | 2.09 | -89.08% | Jersey |
 Novavax NVAX | 0.9708 | -94.94% | 🇺🇸 USA |
 Organovo ONVO | 25.5 | 33.04% | 🇺🇸 USA |
 Orchard Therapeutics
ORTX | 17.4 | -9.19% | 🇬🇧 UK |